USC Roski Eye Institute, Keck School of Medicine of the University of Southern California, Los Angeles, CA 90033, USA.
The Vision Center at Children's Hospital Los Angeles, Los Angeles, CA 90027, USA.
Genes (Basel). 2019 Nov 1;10(11):879. doi: 10.3390/genes10110879.
The gene is the first described human tumor suppressor gene and plays an integral role in the development of retinoblastoma, a pediatric malignancy of the eye. Since its discovery, the stepwise characterization and cloning of have laid the foundation for numerous advances in the understanding of tumor suppressor genes, retinoblastoma tumorigenesis, and inheritance. Knowledge of led to a paradigm shift in the field of cancer genetics, including widespread acceptance of the concept of tumor suppressor genes, and has provided crucial diagnostic and prognostic information through genetic testing for patients affected by retinoblastoma. This article reviews the long history of gene research, characterization, and cloning, and also discusses recent advances in retinoblastoma genetics that have grown out of this foundational work.
该基因是首个被描述的人类肿瘤抑制基因,在眼内恶性肿瘤视网膜母细胞瘤的发生发展中发挥着重要作用。自发现以来, 基因的逐步特征描述和克隆为肿瘤抑制基因、视网膜母细胞瘤发生和遗传的理解奠定了基础。对 基因的认识导致了癌症遗传学领域的范式转变,包括对肿瘤抑制基因概念的广泛接受,并通过对受视网膜母细胞瘤影响的患者进行基因检测提供了关键的诊断和预后信息。本文回顾了 基因研究、特征描述和克隆的悠久历史,并讨论了由此项基础工作衍生出的视网膜母细胞瘤遗传学的最新进展。